RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ

por Meurs, Claudia J C, Menke-Pluijmers, Marian B E, Siesling, Sabine, Westenend, Pieter J
Publicado 2020

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model

por Meurs, Claudia J. C., van Rosmalen, Joost, Menke-Pluijmers, Marian B. E., Siesling, Sabine, Westenend, Pieter J.
Publicado 2022

Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ

por Meurs, Claudia J. C., van Bekkum, Sara, van Rosmalen, Joost, Menke-Pluijmers, Marian B. E., Siesling, Sabine, Westenend, Pieter J.
Publicado 2023

Surgeons’ preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ

por Meurs, Claudia J. C., van Til, Janine A., Menke-Pluijmers, Marian B. E., de Vet, Stefanie, Siesling, Sabine, Westenend, Pieter J.
Publicado 2022

A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers

por Meurs, Claudia J. C., van Rosmalen, Joost, Menke-Pluijmers, Marian B. E., ter Braak, Bert P. M., de Munck, Linda, Siesling, Sabine, Westenend, Pieter J.
Publicado 2018